Selection of aptamers against triple negative breast cancer cells using high throughput sequencing

Triple-negative breast cancer is the most aggressive subtype of invasive breast cancer with a poor prognosis and no approved targeted therapy. Hence, the identification of new and specific ligands is essential to develop novel targeted therapies. In this study, we aimed to identify new aptamers that...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Débora, Barbosa, Joaquim, Sousa, Diana A., Silva, Cátia, Melo, Luís D. R., Avci-Adali, Meltem, Wendel, Hans P., Rodrigues, Ligia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060331/
https://www.ncbi.nlm.nih.gov/pubmed/33883615
http://dx.doi.org/10.1038/s41598-021-87998-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060331/
https://www.ncbi.nlm.nih.gov/pubmed/33883615
http://dx.doi.org/10.1038/s41598-021-87998-y

Ejemplares similares